Increased availability of telehealth mental health and substance abuse treatment for peripartum and postpartum women: A unique opportunity to increase telehealth treatment

J Subst Abuse Treat. 2021 Apr:123:108268. doi: 10.1016/j.jsat.2020.108268. Epub 2021 Jan 5.

Abstract

Since the onset of the COVID-19 pandemic, several federal, state, and payor policy changes have facilitated the uptake of telehealth service delivery. These changes have resulted in a significant uptick in the utilization of maternal mental health and substance use disorder screening and treatment services for pregnant and postpartum women. The Medical University of South Carolina's [MUSC] Women's Reproductive Behavioral Health Program provides outpatient mental health and substance use treatment to pregnant and postpartum women within obstetric practices. With the onset of COVID-19, our program converted all of its screening for and treatment of mental health and substance use disorders to remote platforms. Lessons learned during this time may lay the foundation for transitioning to sustainable telehealth-based referral and delivery of substance use treatment more broadly.

Keywords: COVID-19; Peripartum; Postpartum; Telehealth.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19*
  • Female
  • Humans
  • Maternal Health Services*
  • Pregnancy
  • Pregnancy Complications*
  • Prenatal Care*
  • Referral and Consultation
  • SARS-CoV-2*
  • South Carolina
  • Substance-Related Disorders*
  • Telemedicine*